Q2 2022 · 13F-HR
ACT CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2022-08-12 · accession 0001636587-22-000014
$71,501
Reported value
78
Positions
2022-06-30
Period end
The Brief · ACT CAPITAL MANAGEMENT, LLC · Q2 2022
AI · grounded in 13F
ACT CAPITAL MANAGEMENT, LLC established a new position in STAA valued at $16,236. The fund also initiated new stakes in XOM for $4,873 and ARWR for $4,753. Additional new positions include DVN at $4,547 and KRYS at $3,874. The fund ended the period with 78 positions and total AUM of $71,501.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 852312305 | STAA | STAAR SURGICAL CO | $16,236 | 22.7% | 228,900 | Common | SOLE |
| 30231G102 | XOM | EXXON MOBIL CORP | $4,873 | 6.82% | 56,900 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $4,753 | 6.65% | 135,000 | Common | SOLE |
| 25179M103 | DVN | DEVON ENERGY CORP NEW | $4,547 | 6.36% | 82,500 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $3,874 | 5.42% | 59,000 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $3,567 | 4.99% | 226,600 | Common | SOLE |
| 185063104 | CLSDUSD | CLEARSIDE BIOMEDICAL INC | $3,364 | 4.70% | 2,288,200 | Common | SOLE |
| 166764100 | CVX | CHEVRON CORP NEW | $2,823 | 3.95% | 19,500 | Common | SOLE |
| 00738A106 | ADTNEUR | ADTRAN INC | $2,630 | 3.68% | 150,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2,394 | 3.35% | 173,500 | Common | SOLE |
| 28249U105 | CLDNEUR | EIGER BIOPHARMACEUTICALS INC | $1,575 | 2.20% | 250,000 | Common | SOLE |
| 29415J106 | NVNO | ENVVENO MED CORP | $1,517 | 2.12% | 401,200 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $1,419 | 1.98% | 160,500 | Common | SOLE |
| 29273V100 | ET | ENERGY TRANSFER L P | $1,275 | 1.78% | 127,800 | Common | SOLE |
| 91332U101 | U | UNITY SOFTWARE INC | $968 | 1.35% | 26,300 | Common | SOLE |
| M85548101 | SSYS | STRATASYS LTD | $937 | 1.31% | 50,000 | Common | SOLE |
| 516806205 | 8LP1 | LAREDO PETROLEUM INC | $882 | 1.23% | 12,800 | Common | SOLE |
| N01045108 | — | AFFIMED N V | $855 | 1.20% | 308,800 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HOLDINGS INC | $852 | 1.19% | 12,900 | Common | SOLE |
| 44934S206 | ICADUSD | ICAD INC | $820 | 1.15% | 205,000 | Common | SOLE |
| G637AM102 | MYOVEUR | MYOVANT SCIENCES LTD | $808 | 1.13% | 65,000 | Common | SOLE |
| 125269100 | CF | CF INDUSTRIES HOLDINGS INC | $772 | 1.08% | 9,000 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS INC | $696 | 0.97% | 24,500 | Common | SOLE |
| 45719W106 | IKT | INHIBIKASE THERAPEUTICS INC | $696 | 0.97% | 937,500 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $513 | 0.72% | 51,000 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $500 | 0.70% | 62,500 | Common | SOLE |
| 25278X109 | FANG | DIAMONDBACK ENERGY INC | $485 | 0.68% | 4,000 | Common | SOLE |
| 77543R102 | ROKU | ROKU INC | $460 | 0.64% | 5,600 | Common | SOLE |
| 74760R303 | — | QUALTEK SERVICES INC | $444 | 0.62% | 300,000 | Common | SOLE |
| 25402D102 | DOCN | DIGITALOCEAN HLDGS INC | $414 | 0.58% | 10,000 | Common | SOLE |
| 04537Y109 | — | ASPIRA WOMENS HEALTH INC | $380 | 0.53% | 646,000 | Common | SOLE |
| 98956A105 | ZETA | ZETA GLOBAL HOLDINGS CORP | $328 | 0.46% | 72,500 | Common | SOLE |
| 92837L109 | VIST | VISTA ENERGY S.A.B. DE C.V. | $307 | 0.43% | 41,500 | Common | SOLE |
| 52187K101 | CYPH | LEAP THERAPEUTICS INC | $305 | 0.43% | 265,000 | Common | SOLE |
| 68235C107 | — | ONCOCYTE CORPORATION | $297 | 0.42% | 330,000 | Common | SOLE |
| 86877M209 | SURFUSD | SURFACE ONCOLOGY INC | $280 | 0.39% | 170,500 | Common | SOLE |
| 35953D104 | FUBOGBP | FUBOTV INC | $272 | 0.38% | 110,000 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $265 | 0.37% | 120,600 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $248 | 0.35% | 7,000 | Common | SOLE |
| 68236P107 | GTXIEUR | ONCTERNAL THERAPEUTICS INC | $233 | 0.33% | 210,000 | Common | SOLE |
| 64049K104 | — | NEOLEUKIN THERAPEUTICS INC | $205 | 0.29% | 199,000 | Common | SOLE |
| 58490H107 | MDNAF | MEDICENNA THERAPEUTICS CORP | $173 | 0.24% | 149,070 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $153 | 0.21% | 90,000 | Common | SOLE |
| 53814L108 | LTHM1EUR | LIVENT CORP | $136 | 0.19% | 6,000 | Common | SOLE |
| 26142Q205 | DPRO | DRAGANFLY INC | $122 | 0.17% | 135,000 | Common | SOLE |
| 57055L107 | MRKR | MARKER THERAPEUTICS INC | $117 | 0.16% | 354,400 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $115 | 0.16% | 47,500 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $114 | 0.16% | 27,500 | Common | SOLE |
| 023135106 | AMZN | AMAZON.COM INC | $106 | 0.15% | 1,000 | Common | SOLE |
| 05070N103 | — | AUDACY INC | $92 | 0.13% | 97,500 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N V | $90 | 0.13% | 10,300 | Common | SOLE |
| 15117F500 | CLRB | CELLECTAR BIOSCIENCES INC | $88 | 0.12% | 217,500 | Common | SOLE |
| 12482W200 | YCBD | CBDMD INC | $80 | 0.11% | 22,000 | Common | SOLE |
| 868153107 | SDPIUSD | SUPERIOR DRILLING PRODS INC | $79 | 0.11% | 80,000 | Common | SOLE |
| 23283X206 | CTSO | CYTOSORBENTS CORP | $77 | 0.11% | 35,000 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $72 | 0.10% | 9,200 | Common | SOLE |
| M4130Y106 | ENLV | ENLIVEX THERAPEUTICS LTD | $68 | 0.10% | 15,000 | Common | SOLE |
| 54570M108 | — | LOTTERY COM INC | $63 | 0.09% | 56,000 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $57 | 0.08% | 28,500 | Common | SOLE |
| 12482W101 | YCBD | CBDMD INC | $55 | 0.08% | 125,000 | Common | SOLE |
| 829399104 | AXONEUR | SIO GENE THERAPIES INC | $53 | 0.07% | 146,500 | Common | SOLE |
| 98459U103 | YALA | YALLA GROUP LTD | $53 | 0.07% | 13,500 | Common | SOLE |
| 78472W104 | SQZB | SQZ BIOTECHNOLOGIES CO | $51 | 0.07% | 16,000 | Common | SOLE |
| 03209T109 | AMPE | AMPIO PHARMACEUTICALS INC | $49 | 0.07% | 291,500 | Common | SOLE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $45 | 0.06% | 15,000 | Common | SOLE |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $44 | 0.06% | 12,000 | Common | SOLE |
| 42328V603 | — | HELIUS MED TECHNOLOGIES INC | $42 | 0.06% | 35,263 | Common | SOLE |
| 69242L106 | OYST | OYSTER PT PHARMA INC | $37 | 0.05% | 8,500 | Common | SOLE |
| 09071M205 | — | BIOLINE RX LTD | $35 | 0.05% | 27,500 | Common | SOLE |
| 87184Q107 | SYRS | SYROS PHARMACEUTICALS INC | $34 | 0.05% | 35,000 | Common | SOLE |
| 54570M116 | LTRYW | LOTTERY COM INC | $25 | 0.03% | 125,000 | Common | SOLE |
| 45783C101 | TIL | INSTIL BIO INC | $23 | 0.03% | 5,000 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $19 | 0.03% | 18,777 | Common | SOLE |
| 00973W102 | — | AKERNA CORP | $18 | 0.03% | 128,000 | Common | SOLE |
| 60800C109 | MOGOCAD | MOGO INC | $17 | 0.02% | 19,491 | Common | SOLE |
| 37186H100 | — | GENETRON HOLDINGS LIMITED | $13 | 0.02% | 7,500 | Common | SOLE |
| 009496100 | AIRS | AIRSCULPT TECHNOLOGIES INC | $9 | 0.01% | 1,500 | Common | SOLE |
| 89357L105 | RNAZ | TRANSCODE THERAPEUTICS INC COM | $8 | 0.01% | 6,500 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.